Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial

Taylor, PC, Lee, YC, Fleischmann, R et al. (12 more authors) (2019) Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial. Journal of Clinical Medicine, 8 (6). 831. ISSN 2077-0383

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: baricitinib; disease-modifying antirheumatic drugs; pain perception; outcomes research; patient perspective; rheumatoid arthritis
Dates:
  • Published: 12 June 2019
  • Accepted: 6 June 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Jun 2019 09:30
Last Modified: 14 Jun 2019 15:01
Status: Published
Publisher: MDPI AG
Identification Number: https://doi.org/10.3390/jcm8060831

Download

Share / Export

Statistics